Odyssey Health, Inc. financial data

Symbol
ODYY on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
2300 West Sahara Avenue, Suite 800 #4012, Las Vegas, NV
State of incorporation
NV
Fiscal year end
July 31
Former names
Odyssey Group International, Inc. (to 2/18/2022)
Latest financial report
10-Q - Q4 2024 - Mar 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2.01 % -68.8%
Return On Equity 581 %
Return On Assets -401 % -247%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 96.7M shares +0.36%
Common Stock, Shares, Outstanding 96.7M shares +2.41%
Entity Public Float 6.88M USD -37.5%
Common Stock, Value, Issued 96.7K USD +2.41%
Weighted Average Number of Shares Outstanding, Basic 105M shares +13.8%
Weighted Average Number of Shares Outstanding, Diluted 105M shares -8.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 0 USD -100%
General and Administrative Expense 1.21M USD -17.5%
Operating Income (Loss) 15M USD +86.5%
Net Income (Loss) Attributable to Parent -14.8M USD -239%
Earnings Per Share, Basic -0.15 USD/shares -236%
Earnings Per Share, Diluted -0.13 USD/shares -244%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 7.19K USD -95.7%
Assets, Current 108K USD -58.2%
Assets 267K USD -98.1%
Accounts Payable, Current 1.45M USD +14.8%
Accrued Liabilities, Current 13.8K USD 0%
Liabilities, Current 6.73M USD +25.1%
Retained Earnings (Accumulated Deficit) -62.2M USD -31.3%
Stockholders' Equity Attributable to Parent -6.46M USD -175%
Liabilities and Equity 267K USD -98.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -249K USD -315%
Net Cash Provided by (Used in) Financing Activities 300K USD +35.8%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 96.7M shares +2.41%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 7.19K USD -95.7%
Interest Paid, Excluding Capitalized Interest, Operating Activities 705 USD +28.4%
Deferred Tax Assets, Valuation Allowance 2.86M USD -3.31%
Deferred Tax Assets, Gross 2.86M USD -3.31%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 55.7M USD -0.56%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.54K USD -55%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 594K USD -6.16%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%